top of page
Search
IN VITRO REVOLUTION
Alzheimer's Disease
Idiopathic Pulmonary Fibrosis
Congenital Heart Disease
Type 1 Diabetes Mellitus
Inflammatory Bowel Disease
Amyotrophic Lateral Sclerosis
Thrombocytopenia
Chronic Skin Wounds
INDUSTRY NEWS
Product Launches
Intra-industry Partnerships
M&A Activity
Grants Awarded & Funds Raised
Pharma & Biotech Collaborations
Clinical Trial Authorizations
Regulatory Modernization
TECH FRONTIERS
APPLICATION EXPLORER
Log In
Subscribe to Newsletter
All Posts
Organ-on-a-chip systems
Intra-industry partnerships
Pharma & biotech collaborations
Product Launches
Clinical Trial Outcomes
M&A Activity
Bioprinting
3D tissue platforms
Clinical Trial Authorizations
Regulatory Modernizations
Organoid technologies
Grants Awarded & Funds Raised
Hybrid AI-in vitro platforms
Prof. R. Passier (ASCT) secures ERC Proof of Concept grant to advance multi-heart platform for cardiovascular drug discovery
Grants Awarded & Funds Raised
Sanofi halts riliprubart MOBILIZE phase 3 study in patients with chronic inflammatory demyelinating polyneuropathy
Clinical Trial Outcomes
Prof. L. Griffith (MIT) receives NIH award to advance research into gynecological diseases using microphysiological systems
Grants Awarded & Funds Raised
Mimetas launches OrganoAccess™ perfusable vascular bed for advanced 3D tissue modeling
Product Launches
Genetic Engineering Unlocks Organotypic Vascularization
Organ-on-a-chip systems
Microphysiological systems pioneers launch industry alliance
Intra-industry partnerships
Hesperos establishes strategic sales partnership with AsedaSciences to augment compound safety prediction
Intra-industry partnerships
Hesperos awarded Phase IIB SBIR grant to investigate drug-induced cognitive impairment using its Human-on-a-Chip®
Grants Awarded & Funds Raised
Cedars-Sinai KronosRx team awarded $5M to improve prediction of adverse drug effects
Grants Awarded & Funds Raised
CN Bio launches universal organ-on-a-chip PhysioMimix® Core to facilitate breakthroughs in drug discovery
Product Launches
Hesperos' chronic inflammatory demyelinating polyneuropathy-on-chip instrumental to achieving orphan drug designation
Clinical Trial Authorizations
Qureator's preclinical tumor model featured in world's first animal-free IND approval
Clinical Trial Authorizations
bottom of page